Using both the amount of myeloid-T cell overlap and the CD8+ T cell density, we assigned CRC patient samples into 1 of 4 categories (low/low, high/low, high/high, or low/high) (Figures 4C, D). This evidence concerns the gene CD8A and colorectal carcinoma.